Weybosset Research & Management’s Salesforce CRM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,075
Closed -$359K 40
2024
Q4
$359K Hold
1,075
0.12% 31
2024
Q3
$294K Buy
1,075
+70
+7% +$17.9K 0.1% 38
2024
Q2
$258K Buy
1,005
+10
+1% +$2.68K 0.1% 37
2024
Q1
$12.8K Sell
995
-50
-5% -$14.4K 4.44% 10
2023
Q4
$275K Buy
1,045
+50
+5% +$11.3K 0.1% 34
2023
Q3
$202K Hold
995
0.08% 40
2023
Q2
$210K Sell
995
-620
-38% -$127K 0.08% 39
2023
Q1
$323K Buy
1,615
+40
+3% +$6.76K 0.12% 39
2022
Q4
$209K Hold
1,575
0.08% 54
2022
Q3
$227K Buy
1,575
+125
+9% +$21.2K 0.1% 47
2022
Q2
$264K Buy
+1,450
New +$256K 0.13% 36
2021
Q4
$426K Sell
1,675
-75
-4% -$21.1K 0.16% 33
2021
Q3
$475K Buy
1,750
+125
+8% +$31.7K 0.19% 29
2021
Q2
$397K Buy
1,625
+150
+10% +$34.6K 0.16% 32
2021
Q1
$313K Hold
1,475
0.13% 44
2020
Q4
$328K Sell
1,475
-100
-6% -$24.3K 0.15% 40
2020
Q3
$396K Sell
1,575
-1,050
-40% -$230K 0.22% 33
2020
Q2
$492K Buy
2,625
+1,000
+62% +$168K 0.29% 32
2020
Q1
$224K Hold
1,625
0.16% 48
2019
Q4
$264K Buy
+1,625
New +$255K 0.14% 51

Other funds holding CRM

Weybosset Research & Management's CRM Position: Q1 2025 in Review

Weybosset Research & Management sold out of Salesforce (CRM) in Q1 2025, closing a stake of 1,075 shares — an estimated $359K sold.

Weybosset Research & Management first reported a position in CRM in Q4 2019 and held it in 20 quarters. The position peaked at $492K in Q2 2020. 2,947 funds tracked by Wall St. Rank hold CRM as of Q1 2025.

  • Weybosset Research & Management reported no remaining Salesforce position as of Q1 2025 after selling out during the quarter.
  • Weybosset Research & Management sold 1,075 Salesforce shares in Q1 2025, an estimated $359K.
  • Weybosset Research & Management first reported a position in Salesforce in Q4 2019 and held it in 20 quarters.
  • Weybosset Research & Management's Salesforce position peaked at $492K in Q2 2020.
  • 2,947 funds tracked by Wall St. Rank held Salesforce as of Q1 2025.

Based on Weybosset Research & Management's 13F filing for Q1 2025, filed 9 Apr 2025.